ID   Karpas-707
AC   CVCL_0010
SY   KARPAS-707; Karpas 707; KARPAS 707; Karpas707
DR   ECACC; 22110801
DR   GEO; GSM7701422
DR   GEO; GSM7701423
DR   NCBI_Iran; C505
DR   Wikidata; Q54899503
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=7079750;
RX   PubMed=10936422;
RX   PubMed=11172031;
RX   PubMed=16957166;
RX   PubMed=17254797;
RX   PubMed=23074853;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 35 hours (PubMed=11172031).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: PubMed=17254797 reports a totally different STR profile which we believe to be erroneous. It is: CSF1PO=10,13; D13S317=11; D16S539=12; D18S51=16,18; D21S11=30,31; D3S1358=15; D5S818=11; D7S820=8; D8S1179=12,13; FGA=18,26; TH01=6,10; TPOX=8; vWA=17,18.
CC   Misspelling: CARPAS 707; PubMed=17254797.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ECACC=22110801
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 11,15
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 18,23
ST   Penta D: 9,10
ST   Penta E: 9,10
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 20,21
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
CH   CVCL_9552 ! Karpas-707H
//
RX   PubMed=11172031; DOI=10.1073/pnas.98.4.1799; PMCID=PMC29337;
RA   Karpas, Abraham
RA   Dremucheva, Alla
RA   Czepulkowski, Barbara H.
RT   "A human myeloma cell line suitable for the generation of human
RT   monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1799-1804(2001).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler, Hans Gunther
RA   Matsuo, Yoshinobu
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=16957166; DOI=10.1369/jhc.6A7001.2006; PMCID=PMC3958123;
RA   Andersson, Ann-Catrin
RA   Stromberg, Sara
RA   Backvall, Helena
RA   Kampf, Caroline
RA   Uhlen, Mathias
RA   Wester, Kenneth
RA   Ponten, Fredrik
RT   "Analysis of protein expression in cell microarrays: a tool for
RT   antibody-based proteomics.";
RL   J. Histochem. Cytochem. 54:1413-1423(2006).
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund, Helena
RA   Nilsson, Kenneth
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   PubMed=17254797; DOI=10.1016/j.biologicals.2006.10.001;
RA   Azari, Shahram
RA   Ahmadi, Nahid
RA   Jeddi-Tehrani, Mahmood
RA   Shokri, Fazel
RT   "Profiling and authentication of human cell lines using short tandem
RT   repeat (STR) loci: report from the National Cell Bank of Iran.";
RL   Biologicals 35:195-202(2007).
//
RX   PubMed=7079750; DOI=10.1126/science.7079750;
RA   Karpas, Abraham
RA   Fischer, Patricia E.
RA   Swirsky, David
RT   "Human myeloma cell line carrying a Philadelphia chromosome.";
RL   Science 216:997-999(1982).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   DOI=10.1007/978-1-4613-2823-0_29;
RA   Karpas, Abraham
RT   "Viruses and human leukemia in vitro.";
RL   (In book chapter) Human leukemia. Cytochemical and ultrastructural techniques in diagnosis and research. Developments in Oncology, Vol. 14; Polliack, Aaron (eds.); pp.495-526; Martinus Nijhoff Publishing; Boston; USA (1984).
//
RX   PubMed=3332852; DOI=10.1016/S0950-3536(87)80037-9;
RA   Keating, Armand
RT   "Ph positive CML cell lines.";
RL   Baillieres Clin. Haematol. 1:1021-1029(1987).
//
RX   PubMed=23074853; DOI=10.1134/S1990519X12050136;
RA   Turilova, Victoria I.
RA   Smirnova, Tatyana Dmitriyevna
RT   "Karyotypic variability of human myeloma cell lines.";
RL   Tsitologiia 54:621-636(2012).
//